Notably, factors influencing hypogonadism recovery were negatively tumor size (OR 0.924, 95% CI 0.883–0.982, p = 0.010) and positively prolactin normalization following treatment (OR 5.722, 95% CI 2.067–17.842, p = 0.001). Here, PRL is linked to hypogonadism.